Assessment of Artificial Intelligence for Treatment Decision Recommendation of Adult Skeletal Class III Patients
Launched by CAIRO UNIVERSITY · Aug 13, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of artificial intelligence (AI) to help make treatment decisions for adults with a specific dental condition called skeletal Class III malocclusion. This condition means that the lower jaw is either too big or the upper jaw is underdeveloped, which can cause problems with how the teeth fit together and affect facial appearance. The researchers want to see if AI can accurately suggest the best treatment options and if these suggestions match what experienced orthodontists would recommend.
To participate in this study, individuals must be adults who have already completed their growth and have skeletal Class III malocclusion, but they should not have any other major health conditions or previous jaw surgeries that could complicate their treatment. Participants will provide their dental records and undergo assessments, and in return, they will help researchers understand how reliable AI can be in guiding orthodontic care. If the trial shows that AI can make accurate recommendations, it could lead to quicker and more standardized treatment options for patients with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Skeletally mature patients with CVMI 6.
- • Skeletal class III patients
- • No congenital deformity, syndrome, or cleft.
- • No previous surgical intervention
- • No mandibular transverse functional shift.
- • Normal overjet, overbite after completion of treatment.
- • Patients with well finished occlusion.
- • Patients who have achieved adequate functional and aesthetic results at the end of their treatment.
- • Good quality initial and final lateral cephalometric radiographs.
- • No sex predilection.
- Exclusion Criteria:
- • Adolescents and skeletally immature patients.
- • Patients with pseudo class III.
- • Syndromic patients.
- • Patients with facial deformity at the naso-maxillary complex
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported